PharmaShots | Incisive News in 3 Shots

Subscribe Now

Sirius Therapeutics

Sirius Therapeutics Commences P-I Study of SRSD107 for Treating Thromboembolic Disorders

Sirius Therapeutics Commences P-I Study of SRSD107 for Treating Thromboembolic Disorders

February 2, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us